TMEFF2

gene product
CT120.2, HPP1, TENB2, TPEF, TR
This gene encodes a member of the tomoregulin family of transmembrane proteins. This protein has been shown to function as both an oncogene and a tumor suppressor depending on the cellular context and may regulate prostate cancer cell invasion. Multiple soluble forms of this protein have been identified that arise from both an alternative splice variant and ectodomain shedding. Additionally, this gene has been found to be hypermethylated in multiple cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
346 antibodies from 26 providers.

Antibody properties

General

Applications

or Cancel
Antibody
OriGene
27 antibodies
antibodies-online
128 antibodies
Novus Biologicals
49 antibodies
GeneTex
4 antibodies
Proteintech Group
1 antibody
Acris Antibodies GmbH
2 antibodies
Abnova Corporation
5 antibodies
NovoPro Bioscience Inc.
1 antibody
LifeSpan BioSciences, Inc.
43 antibodies
Invitrogen Antibodies
4 antibodies
R&D Systems
2 antibodies
RabMAbs
4 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
Affinity Biosciences
1 antibody
Biorbyt
11 antibodies
Creative Biolabs
30 antibodies
Creative Diagnostics
3 antibodies
Atlas Antibodies
1 antibody
Aviva Systems Biology
1 antibody
MyBioSource
5 antibodies
St John's Laboratory
2 antibodies
Abgent
1 antibody
United States Biological
3 antibodies
RayBiotech, Inc.
1 antibody
Sigma-Aldrich
1 antibody